Endra Life Sciences Q2 Update: 4.71 USD Share, Tech‑Driven Growth Outlook
Endra Life Sciences (NDRA) trades near its 200‑day SMA, offering upside potential with thermoacoustic imaging tech that could reshape ultrasound diagnostics.
3 minutes to read